HealthEquity, Inc. (HQY) VP Darcy G. Mott Sells 9,500 Shares
HealthEquity, Inc. (NASDAQ:HQY) VP Darcy G. Mott sold 9,500 shares of the business’s stock in a transaction that occurred on Monday, November 20th. The stock was sold at an average price of $49.68, for a total transaction of $471,960.00. Following the completion of the sale, the vice president now directly owns 93,500 shares of the company’s stock, valued at $4,645,080. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
HealthEquity, Inc. (NASDAQ:HQY) traded up $1.30 during trading on Wednesday, reaching $51.31. 321,100 shares of the company traded hands, compared to its average volume of 530,656. HealthEquity, Inc. has a twelve month low of $37.62 and a twelve month high of $55.31. The company has a market cap of $3,025.04, a price-to-earnings ratio of 79.38, a price-to-earnings-growth ratio of 2.19 and a beta of 1.77.
HealthEquity (NASDAQ:HQY) last announced its earnings results on Tuesday, September 5th. The company reported $0.27 EPS for the quarter, topping the consensus estimate of $0.14 by $0.13. The firm had revenue of $56.90 million for the quarter, compared to the consensus estimate of $55.66 million. HealthEquity had a net margin of 20.27% and a return on equity of 13.93%. The business’s quarterly revenue was up 28.7% on a year-over-year basis. During the same period last year, the company posted $0.16 EPS. analysts predict that HealthEquity, Inc. will post 0.7 EPS for the current fiscal year.
A number of brokerages have weighed in on HQY. Zacks Investment Research downgraded shares of HealthEquity from a “buy” rating to a “hold” rating in a report on Wednesday, November 15th. BidaskClub upgraded shares of HealthEquity from a “sell” rating to a “hold” rating in a research note on Thursday, September 28th. TheStreet upgraded shares of HealthEquity from a “c” rating to a “b” rating in a research note on Monday, July 31st. Robert W. Baird restated a “hold” rating on shares of HealthEquity in a research note on Thursday, September 21st. Finally, Oppenheimer Holdings, Inc. restated a “buy” rating and issued a $61.00 price objective on shares of HealthEquity in a research note on Wednesday, September 6th. Three research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus target price of $57.50.
A number of institutional investors and hedge funds have recently modified their holdings of the stock. Vanguard Group Inc. boosted its position in HealthEquity by 3.0% during the second quarter. Vanguard Group Inc. now owns 4,237,298 shares of the company’s stock worth $211,145,000 after purchasing an additional 122,061 shares during the period. First Trust Advisors LP boosted its position in HealthEquity by 17.0% during the second quarter. First Trust Advisors LP now owns 94,283 shares of the company’s stock worth $4,698,000 after purchasing an additional 13,676 shares during the period. Dimensional Fund Advisors LP boosted its position in HealthEquity by 25.3% during the second quarter. Dimensional Fund Advisors LP now owns 473,433 shares of the company’s stock worth $23,591,000 after purchasing an additional 95,514 shares during the period. Fred Alger Management Inc. boosted its position in shares of HealthEquity by 30.4% in the second quarter. Fred Alger Management Inc. now owns 265,369 shares of the company’s stock valued at $13,223,000 after acquiring an additional 61,880 shares during the period. Finally, Russell Investments Group Ltd. bought a new stake in shares of HealthEquity in the second quarter valued at about $1,362,000. Institutional investors and hedge funds own 93.19% of the company’s stock.
HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.
Receive News & Ratings for HealthEquity Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.